Flow Cytometry Market

Becton, Dickinson and Company (US) and Beckman Coulter, Inc. (US) are leading players in Flow Cytometry Market

The global flow cytometry market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, at a CAGR of 8.1%. Growth in the flow cytometry market can be attributed to factors such as technological advancements in flow cytometers, the increasing adoption of flow cytometry techniques in research activities and clinical trials, growing focus on immunology and immuno-oncology research, high incidence and prevalence of HIV-AIDS and cancer, and the increasing availability of novel flow cytometry products. On the other hand, high costs, a dearth of skilled professionals, and insufficient knowledge regarding the use of flow cytometers are expected to limit market growth to a certain extent. The inadequate infrastructure for research in emerging countries, complexities related to reagent development, and limited purchasing power of end users in emerging countries may also pose challenges to market growth in the coming years.

The major players operating in the flow cytometry market include Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US), and Apogee Flow Systems Ltd. (UK). The analysis of market developments between 2015 and 2018 revealed that product launches and enhancements; partnership and collaborations; and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the flow cytometry market. Product launches and approvals were the most widely adopted growth strategies by market players.

To know about the assumptions considered for the study download the pdf brochure

Becton, Dickinson and Company (US) holds the leading share in the global flow cytometry market. The company has an extensive product portfolio. The company operates globally, with a strong distribution network across North America, Europe, Asia Pacific, Europe, the Middle East, and Africa. To maintain its position in the market, the company has been focusing on technological advancements in all segments of flow cytometry. In the last three years, the company has launched several products, such as BD Precise whole-transcriptome analysis (WTA) reagents, BD FACSMelody System, BD FACSymphony, BD FACSPresto system, BD FACSCelesta system, and BD FACSVia flow cytometer. In addition, the company focuses on partnerships and collaborations for the development of advanced flow cytometry products. For instance, it collaborated with NanoString Technologies, Inc. (US) to develop single-cell isolation and analysis workflows, while its partnership with FlowJo (US) helped it to integrate its flow cytometry data acquisition software with FlowJo’s data analysis platform.

Beckman Coulter (US) held the second position in the market. The strong position of the company in the market can be attributed to its wide product portfolio and strong client base (including biotechnology and pharmaceutical companies, universities, medical schools, and research institutions) in the field of flow cytometry. To maintain its position in the market, the company has been focusing on product launches, partnerships and collaborations, and acquisitions. In 2015, the company entered into a distribution agreement with IncellDx, Inc. (US) to focus exclusively on clinical research customers. Likewise, its collaboration with Genera Biosystems Limited (Australia) strengthened Beckman Coulter’s R&D capabilities. Additionally, the company launched a range of novel flow cytometry products, including CytoFLEX Flow cytometer, Aquios CL clinical flow cytometer, and ClearLLab LS lymphoid screen reagents in the last three years.

Related Reports:

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, and Region - Global Forecast to 2023

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Report Code
BT 6015
Published ON
Jan, 2019
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Flow Cytometry Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved